PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Income Growth
21.39%
Quarterly · Period ending:
PHAS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported21.39%period ending
Latest reported21.39%period ending
PHAS Quarterly Operating Income YoY % (-163.80% → 21.39%)
Year-over-year change
High-resolution chart · PNG
PHAS operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 21.3936% | |
| 57.1373% | |
| 429.0076% | |
| -39.4495% | |
| 12.6359% | |
| -79.5003% | |
| -130.3014% | |
| -76.8076% | |
| -154.1447% | |
| -93.4995% | |
| -47.2585% | |
| -131.8464% | |
| -130.8741% | |
| -156.5671% | |
| -212.5255% | |
| -163.7995% |